Home › Trial NCT01335269
A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer
- Trial IDNCT01335269
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorBoehringer Ingelheim
- Enrollment96
- Start date2011-07
- ConditionsNeoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.